Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23M Buy
151,100
+105,331
+230% +$17.5M 0.1% 189
2026
Q1
$9.6M Sell
45,769
-20,733
-31% -$5.21M 0.05% 285
2025
Q4
$18.9M Buy
66,502
+30,225
+83% +$9.45M 0.09% 195
2025
Q3
$11.2M Sell
36,277
-40,485
-53% -$12.7M 0.06% 257
2025
Q2
$24.1M Buy
76,762
+23,570
+44% +$6.8M 0.14% 142
2025
Q1
$14M Buy
53,192
+32,440
+156% +$8.78M 0.09% 203
2024
Q4
$5.42M Sell
20,752
-6,309
-23% -$1.59M 0.03% 349
2024
Q3
$6.3M Buy
27,061
+11,320
+72% +$2.32M 0.04% 320
2024
Q2
$3.18M Buy
15,741
+481
+3% +$86.7K 0.02% 410
2024
Q1
$2.62M Buy
15,260
+924
+6% +$172K 0.02% 459
2023
Q4
$3.11M Sell
14,336
-59,620
-81% -$10.2M 0.02% 411
2023
Q3
$11.8M Sell
73,956
-2,184
-3% -$489K 0.08% 212
2023
Q2
$22M Buy
76,140
+27,860
+58% +$8.46M 0.16% 146
2023
Q1
$14.2M Buy
48,280
+30,294
+168% +$8.98M 0.1% 210
2022
Q4
$5.29M Sell
17,986
-39,670
-69% -$10.9M 0.04% 366
2022
Q3
$13.2M Buy
57,656
+6,531
+13% +$1.64M 0.09% 219
2022
Q2
$11.1M Buy
51,125
+40,977
+404% +$9.31M 0.09% 211
2022
Q1
$2.7M Sell
10,148
-5,275
-34% -$1.29M 0.02% 480
2021
Q4
$4.1M Buy
15,423
+11,568
+300% +$3.36M 0.03% 395
2021
Q3
$1.1M Sell
3,855
-237
-6% -$67.6K 0.01% 684
2021
Q2
$1.12M Buy
4,092
+594
+17% +$161K 0.01% 698
2021
Q1
$859K Hold
3,498
0.01% 656
2020
Q4
$894K Hold
3,498
0.01% 668
2020
Q3
$828K Buy
+3,498
New +$737K 0.01% 640

Other funds holding PODD

Candriam SCA's PODD Position: Q2 2026 in Review

Candriam SCA increased its Insulet (PODD) stake by 230% in Q2 2026, buying an estimated $17.5M and bringing the position to 151,100 shares worth $23M. The position accounts for 0.1% of the portfolio, ranked #189.

Candriam SCA first reported a position in PODD in Q3 2020 and has held it in 24 quarters since. The position peaked at $24.1M in Q2 2025. 723 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Candriam SCA held 151,100 shares of Insulet worth $23M as of Q2 2026.
  • Candriam SCA bought 105,331 Insulet shares in Q2 2026, an estimated $17.5M.
  • Insulet made up 0.1% of Candriam SCA's portfolio in Q2 2026, its #189 holding.
  • Candriam SCA first reported a position in Insulet in Q3 2020 and has held it in 24 quarters since.
  • Candriam SCA's Insulet position peaked at $24.1M in Q2 2025.
  • 723 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.